129 related articles for article (PubMed ID: 23518210)
1. Time trends in survival from cancer of unknown primary: small steps forward.
Riihimäki M; Hemminki A; Sundquist K; Hemminki K
Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
[TBL] [Abstract][Full Text] [Related]
2. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
3. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
4. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
[TBL] [Abstract][Full Text] [Related]
5. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.
Riihimäki M; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2014 Jun; 14():439. PubMed ID: 24929562
[TBL] [Abstract][Full Text] [Related]
6. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
8. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
Hemminki K; Bevier M; Sundquist J; Hemminki A
Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
Bevier M; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
[TBL] [Abstract][Full Text] [Related]
10. Survival in cancer of unknown primary site: population-based analysis by site and histology.
Hemminki K; Bevier M; Hemminki A; Sundquist J
Ann Oncol; 2012 Jul; 23(7):1854-63. PubMed ID: 22115926
[TBL] [Abstract][Full Text] [Related]
11. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
[TBL] [Abstract][Full Text] [Related]
12. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
13. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
[TBL] [Abstract][Full Text] [Related]
14. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
[TBL] [Abstract][Full Text] [Related]
15. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
[TBL] [Abstract][Full Text] [Related]
16. Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.
Binder C; Matthes KL; Korol D; Rohrmann S; Moch H
Cancer Med; 2018 Sep; 7(9):4814-4824. PubMed ID: 30019510
[TBL] [Abstract][Full Text] [Related]
17. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
18. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma.
Lu Y; Fröbom R; Lagergren J
Cancer Epidemiol; 2012 Jun; 36(3):e158-63. PubMed ID: 22405637
[TBL] [Abstract][Full Text] [Related]
19. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Holmberg L
Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
[TBL] [Abstract][Full Text] [Related]
20. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
Brustugun OT; Helland Å
Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
